Aflac 2014 Annual Report Download - page 14

Download and view the complete annual report

Please find page 14 of the 2014 Aflac annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 40

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40

12
In 2014, Aflac celebrated a monumental milestone: 40 years of operating in Japan.
Over the years, many things in Japan have changed, including the economy,
demographics and competition. But one thing has not changed: our focus on
helping provide Japanese citizens with financial assistance when a health event or
life situation causes challenges. Our determination to live the Aflac legacy means
we compassionately and steadfastly fulfill our promise of being there for our policy-
holders, with a focus on paying claims quickly and accurately.
In 1974, we entered Japan as the pioneer of cancer insurance. At that time,
cancer was the second-leading cause of death, so this product addressed a signif-
icant need in Japan. In 1981, cancer became the number one cause of death.
Over the years, we’ve also grown to become an innovator and provider of other
supplemental products. We are driven each day to remain good stewards of the trust
that more than 15 million Japanese policyholders have placed in us over the last four
decades. This has allowed us to grow and become the leading provider of medical
and cancer insurance in Japan. Today, we insure one in four Japanese households.
In 2014, Aflac Japan’s sales objective focused on the sale of cancer and medical
products. These policies are more profitable and less interest-rate sensitive than life
insurance or annuity products, which is especially important in the low-interest-rate
environment. For 2014, our target was to increase cancer and medical policy sales
in the range of 2% to 7%. We were very pleased that sales for these products
increased 6.1% for the year.
2014 FINANCIAL HIGHLIGHTS
IN YEN
Premium income rose 0.1%
to ¥1.46 trillion.
Total revenues rose 1.3%
to ¥1.75 trillion.
Pretax operating earnings
rose 3.1% to ¥364.7 billion.
2014 FINANCIAL HIGHLIGHTS
IN DOLLARS
Premium income declined
7.5% to $13.9 billion.
Total revenues declined
6.4% to $16.6 billion.
Pretax operating earnings
declined 4.7% to $3.5 billion.
Aflac Japan
Celebrating a 40-Year Legacy of Protecting Our Policyholders